Literature DB >> 7335958

Studies of the growth of a murine renal cell carcinoma and its metastatic patterns.

P D Williams, E J Pontes, G P Murphy.   

Abstract

Metastatic lung tumor cells from a murine renal cell adenocarcinoma were implanted in Blab/C mice for 12 transfer generations. Survival time of the implanted mice was observed to decrease from 48 days to 28 days. The incidence of lung metastases increased from 40% to 90%. These studies suggest a selection process under the terms of the experiment that has resulted in a change in the metastatic potential of the primary tumor and its serial passage of metastases. The results are compatible with current concepts regarding cell selection in this cancer state but do not, at the present time, precisely define how this is achieved. Appropriate and selective studies are ongoing to address this important issue.

Entities:  

Mesh:

Year:  1981        PMID: 7335958

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  4 in total

1.  mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment.

Authors:  Qun Jiang; Jonathan M Weiss; Timothy Back; Tim Chan; John R Ortaldo; Sylvie Guichard; Robert H Wiltrout
Journal:  Cancer Res       Date:  2011-05-03       Impact factor: 12.701

2.  Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.

Authors:  Jonathan M Weiss; Jeff J Subleski; Tim Back; Xin Chen; Stephanie K Watkins; Hideo Yagita; Thomas J Sayers; William J Murphy; Robert H Wiltrout
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

3.  Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy.

Authors:  Jonathan M Weiss; Lisa A Ridnour; Tim Back; S Perwez Hussain; Peijun He; Anna E Maciag; Larry K Keefer; William J Murphy; Curtis C Harris; David A Wink; Robert H Wiltrout
Journal:  J Exp Med       Date:  2010-10-04       Impact factor: 14.307

4.  Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment.

Authors:  Jonathan M Weiss; Timothy C Back; Anthony J Scarzello; Jeff J Subleski; Veronica L Hall; Jimmy K Stauffer; Xin Chen; Dejan Micic; Kory Alderson; William J Murphy; Robert H Wiltrout
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.